A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: A phase II study
Research output: Contribution to journal › Article › peer-review
18Scopus
citations
Fingerprint
Dive into the research topics of 'A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: A phase II study'. Together they form a unique fingerprint.